Nasal allergy (Allergic Rhinitis, AR) is a common condition affecting both the young and the old. It is the most common immunological disease affecting mankind. The prevalence of allergic rhinitis is about 40% in Singapore. House-dust mite and house-dust (fecal matter of the house-dust mite) is the most common cause of aero-allergenic AR in Singapore.
Rhinitis, by definition, is an inflammation of the lining of the nasal passage (mucosa). It presents with nasal discharge (runny nose), itching, sneezing and nasal blockage or congestion. Rhinitis can be caused by a variety of factors, allergy being one. It can also be non-allergic, infective or a combination of factors.
Allergic rhinitis is a risk factor for asthma and affects the control of asthma as well. A combination of the two conditions increases the cost of managing both. AR in early childhood is a risk factor for future development of asthma in adult life. Approximately 80% of patients with asthma report symptoms of rhinitis and vice-versa.
AR is associated with other ‘allergy’ states (i.e. atopy) such as eczema and food allergy. AR also affects the eyes (conjunctivitis), reduces the sense of smell (hyposmia), affects the middle ear and potentially reduces hearing, irritates the throat and can affect the voice box.
Middle ear inflammation and swelling of the adenoids (lymphoid tissue found at the back of the nose) may be associated with AR too. Occupational rhinitis i.e. rhinitis caused by airborne substances in the work environment affecting the nasal lining can affect the individuals primarily or affect predisposing asthma and potentially even cause it.
Examination of the ear, nose and throat looking for signs of AR includes looking for an ‘allergic salute’ – a horizontal nasal crease across the front of the nose above the tip, and dark circle around the eyes due to pooling of blood around the eyes (i.e. shiners).
Inspection of the front of the nasal passages (anterior rhinoscopy) looking at the health of the nasal lining, any swelling of the side walls of the nose (turbinates) and deviation in the nasal partition (septum) will be documented.
We can perform nasal endoscopy for adults and young children at our specialist centre. The examination allows for visualization of the back of the nose and throat. Other conditions that may affect the nose such as infections, polyps and adenoidal swellings are easily picked up on nasendocopy.
The mainstay of diagnostic testing in subjects with AR are tests that assess a type of immunoglobulin in the skin or blood serum. These molecules (i.e. immunoglobulins) are effectively antibodies that are produced by a specific type of cell as part of the body’s immune system. The allergen-specific immunoglobulin is called IgE. Skin prick tests (SPT) are a routine and involve the pricking /scratching of the skin while inserting a purified sample of the known allergen. A positive SPT does not always mean that the individual is allergic to a particular allergen – up to 15% of individuals who do not exhibit any AR. Serum (blood) tests are more specific and serum specific IgE can be tailored according to the profile and possible exposure of the patient.
Call us at 6931 8000 to arrange an allergy blood test or swab test .
Allergic rhinitis in Singapore is predominantly due to house dust mite allergy. While seasonal allergens are more easily avoided and do not affect the patient throughout the year, the house dust mite allergy sufferer has a greater challenge facing him or her given the practical challenges of reducing exposure.
Antihistamines: These drugs that stop the release of histamine, which is secreted by cells found in the nose, throat and eye. These drugs can be administered orally, as nasal sprays or eye drops. The older generation antihistamines causes more ‘central’ effects such as drowsiness. The newer ‘2nd’ generation antihistamines are longer acting and have a less sedating effect. Antihistamines are the first line treatment for mild to moderate symptoms of AR. The topical intranasal compounds have been shown to help with faster onset of action.
Corticosteroids: This class of drugs is the cornerstone of the anti-inflammatory treatment in AR and are administered intranasally as sprays. They are suitable in children and adults depending on the preparation and manufacturer’s recommendations. They reduce nasal congestion and have a much better effect in comparison to other therapeutic groups such as the antihistamines. Intranasal steroids (INS) can take several hours to take effect and clinical improvement can take a few days with even a fortnight for maximal effect. Unlike their oral counterparts, the newer INS have much lower to negligible absorption into the bloodstream thus reducing systemic side effects (low bioavailability). As such, they are also used in children.
INS can cause mild insomnia and can raise the intraocular pressure in glaucoma patients. They are ideal in patients with moderate to severe symptoms and can be used in conjunction with antihistamines. Combination treatments where a topical antihistamine and INS are mixed have been shown to help all nasal symptoms of AR in addition to ocular complaints.
Nasal decongestants: These reduces the swelling of the nasal lining temporarily. They work much faster than INS and may be tempting to use in the long term given their immediate effect. However, it is not recommended for long term use given the rebound nasal congestion after. A three-to five-day course (maximum) is recommended. Another class of drugs known as the anti-leukotrienes have been used with some success in asthma and AR sufferers. They are well tolerated but do not have the same effect in managing inflammation as the INS. Another class of drugs which may help in watery discharge, the anti-cholinergics (e.g. ipratropium bromide) can be used in combination with INS when necessary. Finally, cromoglycates, a class of drugs that aim to prevent histamine release from sensitized cells can help in mild AR and used as eyedrops for ocular symptoms.
Immunotherapy: This form of therapy aims to re-educate and ‘calm-down’ the immune response by habituation and development of ‘tolerance’ to an allergen. Subcutaneous immunotherapy (SCIT) involves the incremental injections of purified allergen under the skin over a period in a controlled manner and setting. This process can take up 3-5 years with 4-6 weekly injection. Access to emergency resuscitation facilities are imperative however given the risks of anaphylaxis (severe life-threatening allergic reaction). Sublingual Immunotherapy (SLIT) involves placing a tablet or drops of purified allergen under the tongue. It is generally well tolerated and has been effective for grass pollen and house dust mite. Besides side-effects such as oral irritation and mouth swelling, it is safe and can be administered by the patient at home. In summary, immunotherapy is the only treatment that has the capability to modify the immunological course of AR and has been shown to reduce or obviate the need for INS and other treatments.
Surgery: Given that AR is primarily an immune mediated condition, the role of surgery is limited to dealing with anatomical issues such as a deviated septum, inferior turbinate hypertrophy, concomitant chronic rhinosinusitis and in so doing help with more efficient drug delivery.